Skip to main content
. 2019 Jul 17;93(15):e00305-19. doi: 10.1128/JVI.00305-19

TABLE 1.

Demographic characteristicsa

Characteristic Value
Group 1 (booster ZVL recipients ≥70 yr old) Group 2 (first-time ZVL recipients ≥70 yr old) Group 3 (first-time ZVL recipients 60–69 yr old) Group 4 (first-time ZVL recipients 50–59 yr old) Total
No. of participants/group 201 199 100 100 600
No. (%) of patients of gender
    Male 94 (46.8) 105 (52.8) 35 (35.0) 23 (23.0) 257 (42.8)
    Female 107 (53.2) 94 (52.8) 65 (65.0) 77 (77.0) 343 (57.2)
Mean age (yr) (SD) 77.1 (4.5) 76.3 (5.1) 64.1 (3.1) 55.5 (2.8) 71.1
Median age (yr) 76.0 75.0 63.0 56.0 73.0
No. (%) of patients of race
    Native American or Asian 0 (0.0) 4 (2.0) 1 (1.0) 0 (0.0) 2 (0.3)
    Black 1 (0.5) 5 (2.5) 8 (8.0) 6 (6.0) 20 (3.3)
    White 200 (99.5) 188 (94.5) 90 (90.0) 93 (93.0) 571 (95.2)
No. (%) of patients of ethnicity
    Hispanic 2 (1.0) 2 (1.0) 0 (0.0) 4 (4.0) 8 (1.3)
    Not Hispanic 198 (98.5) 196 (98.5) 100 (100.0) 96 (96.0) 590 (98.3)
a

Abbreviations: ZVL, live zoster vaccine; SD, standard deviation.